Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Molecule Holdings Inc.

EVRRF

HealthcareOTCCA

$0.0025

$0.00 (+0.00%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

EVRRF

1Y0 (0.00%)

Candles, volume, SMA 20, and SMA 50

O 0.0025H 0.0025L 0.0025C 0.0025Date Jun 5

EVRRF

SMA 20 SMA 50 Vol 1.00KEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It offers its beverage products under the PHRESH, embody, and CANAJO brands. The company is based in Lansdowne, Canada.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$626,130

Volume?1.00K

Avg Volume?10.58K

52w Range$0.0025 - $0.0025

Beta?-0.45

Price Performance

0.0%

$0.0025 to $0.0025

YTD

0.0%

$0.0025 to $0.0025

0.0%

$0.0025 to $0.0025

-51.0%

$0.0051 to $0.0025

-99.8%

$1.00 to $0.0025

10Y

N/A

history unavailable

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEODavid Reingold

IndustryDrug Manufacturers - Specialty & Generic

Employees13

IPO Date2020-09-22

CurrencyUSD

Websitewww.molecule.ca

Related stocks

Check out other names from the same Drug Manufacturers - Specialty & Generic industry as EVRRF.

CareView Communications, Inc.

0.05USD

N/A

CWBHF-

Charlotte's Web Holdings, Inc.

0.43USD

N/A

GBLP-

Global Pharmatech, Inc.

0.08USD

N/A

ISCNF-

Isracann Biosciences Inc.

Raphael Pharmaceutical Inc.

1.40USD

N/A